[go: up one dir, main page]

PE20020194A1 - 2,3,7,8,9,10,11,12-OCTAHIDROAZEPINO[4,5-b]PIRANO[3,2-e)INDOLES SUSTITUIDOS - Google Patents

2,3,7,8,9,10,11,12-OCTAHIDROAZEPINO[4,5-b]PIRANO[3,2-e)INDOLES SUSTITUIDOS

Info

Publication number
PE20020194A1
PE20020194A1 PE2001000661A PE2001000661A PE20020194A1 PE 20020194 A1 PE20020194 A1 PE 20020194A1 PE 2001000661 A PE2001000661 A PE 2001000661A PE 2001000661 A PE2001000661 A PE 2001000661A PE 20020194 A1 PE20020194 A1 PE 20020194A1
Authority
PE
Peru
Prior art keywords
pyrane
alkyl
octahydroazepine
indeols
substitute
Prior art date
Application number
PE2001000661A
Other languages
English (en)
Inventor
Jian-Min Fu
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PE20020194A1 publication Critical patent/PE20020194A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE A UN COMPUESTO DE PIRANO AZEPINOINDOL DE FORMULA I DONDE R1 ES H, ALQUILO C1-C6, ENTRE OTROS; R2 ES H, ALQUILO C1-C4, OH; R3 ES H, ALQUILO, ARILO, HETEROARILO, CORa, CONRaRb, ENTRE OTROS; R4 ES H, HALO, OH, CN, NO2, ENTRE OTROS; Ra Y Rb SON ALQUILO C1-C6, CICLOALQUILO C3-C8, ARILO, HETEROARILO, ENTRE OTROS. SON COMPUESTOS PREFERIDOS 10-BENCIL-7,8,9,10,11,12-HEXAHIDRO-3H-AZEPINO-[4,5-b]PIRANO[3,2-e]INDOL, 2,3,7,8,9,10,11,12-OCTAHIDRO-1H-AZEPINO[4,5-b]PIRANO[3,2-e]INDOL, ENTRE OTROS. EL COMPUESTO ES MODULADOR DEL RECEPTOR AGLUTINANTE DE SEROTONINA 5-HT Y PUEDE SER UTIL PARA EL TRATAMIENTO DE OBESIDAD, DEPRESION, ESQUIZOFRENIA, DESORNES ILUSORIOS; UTILIZANDOSE DE 0,1mg/Kg a 10mg/Kg
PE2001000661A 2000-07-06 2001-07-04 2,3,7,8,9,10,11,12-OCTAHIDROAZEPINO[4,5-b]PIRANO[3,2-e)INDOLES SUSTITUIDOS PE20020194A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21628600P 2000-07-06 2000-07-06

Publications (1)

Publication Number Publication Date
PE20020194A1 true PE20020194A1 (es) 2002-03-02

Family

ID=22806475

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000661A PE20020194A1 (es) 2000-07-06 2001-07-04 2,3,7,8,9,10,11,12-OCTAHIDROAZEPINO[4,5-b]PIRANO[3,2-e)INDOLES SUSTITUIDOS

Country Status (7)

Country Link
US (1) US6503899B2 (es)
EP (1) EP1296988A1 (es)
AR (1) AR028742A1 (es)
AU (2) AU2001269781A1 (es)
PE (1) PE20020194A1 (es)
TW (1) TWI248442B (es)
WO (2) WO2002004456A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR034264A1 (es) * 2000-09-20 2004-02-18 Upjohn Co Derivados azepino(4,5-b)indol sustituidos y composiciones farmaceuticas
US20030060462A1 (en) * 2001-08-06 2003-03-27 Hoffman Robert L. Therapeutic compounds
US8685924B2 (en) 2004-08-25 2014-04-01 Takeda Pharmaceutical Company Limited Preventives/remedies for stress urinary incontinence and method of screening the same
EP2018863B9 (en) 2006-05-16 2015-02-18 Takeda Pharmaceutical Company Limited Fused heterocyclic compound and use thereof
JP5520051B2 (ja) 2007-11-15 2014-06-11 武田薬品工業株式会社 縮合ピリジン誘導体およびその用途
CA2727055C (en) 2008-01-11 2016-12-20 Albany Molecular Research, Inc. (1-azinone) -substituted pyridoindoles as mch antagonists
EP2448585B1 (en) 2009-07-01 2014-01-01 Albany Molecular Research, Inc. Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003007A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en) 2009-07-01 2011-01-06 Albany Molecular Research, Inc. Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
WO2011071136A1 (ja) 2009-12-11 2011-06-16 アステラス製薬株式会社 線維筋痛症治療剤
US8697700B2 (en) 2010-12-21 2014-04-15 Albany Molecular Research, Inc. Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
US8993765B2 (en) 2010-12-21 2015-03-31 Albany Molecular Research, Inc. Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
US12343337B2 (en) 2016-09-29 2025-07-01 The Regents Of The University Of California Compounds for increasing neural plasticity
WO2019131902A1 (ja) 2017-12-27 2019-07-04 武田薬品工業株式会社 腹圧性尿失禁および便失禁の治療薬
WO2020176599A1 (en) 2019-02-27 2020-09-03 The Regents Of The University Of California Azepino-indoles and other heterocycles for treating brain disorders
TW202333668A (zh) 2021-12-15 2023-09-01 美商德利克斯醫療公司 經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR35044B (el) * 1966-05-10 1968-07-31 The Upjohn Company Μεθοδος παρασκευης οργανικων ενωσεων.
US3839357A (en) 1966-05-10 1974-10-01 Upjohn Co 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
US3553232A (en) 1967-08-25 1971-01-05 Upjohn Co 4-(1,4,5,6-tetrahydroazepine(4,5-b)indole-3(2h)-yl)butyrophenones
US3622673A (en) * 1968-11-14 1971-11-23 Upjohn Co 4-(1,4,5,6-TETRAHYDROZEPINO 4,5-b INDOL-3(2H)-YL-BUTYROPHENON COMPOSITIONS AND PROCESS OF TREATMENT MENTAL OR EMOTIONAL DISORDERS
US3652588A (en) 1969-10-23 1972-03-28 Upjohn Co 6-alkyl-1 2 3 4 5 6-hexahydroazepino(4 5-b)indoles
US3676558A (en) 1970-08-28 1972-07-11 Upjohn Co Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment
US3776922A (en) * 1972-03-24 1973-12-04 J Epstein Indole carboxaldehydes
ATE12641T1 (de) * 1979-11-02 1985-04-15 Sandoz Ag Azepinindole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PE20010052A1 (es) * 1999-04-23 2001-01-27 Upjohn Co Compuestos de azepinindol tetraciclico como agonistas o antagonistas del receptor de 5-ht

Also Published As

Publication number Publication date
TWI248442B (en) 2006-02-01
WO2002004457A1 (en) 2002-01-17
EP1296988A1 (en) 2003-04-02
AR028742A1 (es) 2003-05-21
AU2001271876A1 (en) 2002-01-21
US6503899B2 (en) 2003-01-07
WO2002004457A8 (en) 2002-03-21
WO2002004456A1 (en) 2002-01-17
AU2001269781A1 (en) 2002-01-21
US20020022616A1 (en) 2002-02-21

Similar Documents

Publication Publication Date Title
PE20020194A1 (es) 2,3,7,8,9,10,11,12-OCTAHIDROAZEPINO[4,5-b]PIRANO[3,2-e)INDOLES SUSTITUIDOS
PE20060555A1 (es) Derivados de pirrol-oxindol como moduladores del receptor de progesterona
PE20010522A1 (es) Aminoalcoxicarbazoles como antagonistas de los receptores 5ht
PE20020510A1 (es) DERIVADOS DE AZEPILO [4,5b] INDOLINA SUSTITUIDOS COMO LIGANDOS DE LOS RECEPTORES DE SEROTONINA (5-HT)
PE20000339A1 (es) Biciclo [2.2.1] heptanos y compuestos relacionados
MX2007009353A (es) Ciclohexilamidas como antagonistas de la dopamina d3, d2 y 5ht1a.
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
PE20030199A1 (es) Derivados de n-[benzoil]-fenilsulfonamida
FI943247A0 (fi) Piperatsiinijohdannaisia 5-HT-reseptoriantagonisteina
UY25873A1 (es) Derivados de 3-azabiciclo [3.1.0] hexano útiles en terapia en afecciones mediadas por receptores opiáceos
PE20030471A1 (es) Compuesto de imidazopiridin como moduladores del receptor 5-ht4
TW200510440A (en) Novel compounds
MXPA02000973A (es) Benzofurilpiperazinas y benzofurilhomopiperazinas: agonistas de serotonina.
CO5200848A1 (es) Derivados de 3(5)-ureido-pirazol, proceso para su prepa- racion y su utilizacion como agentes antitumorales
PE20050131A1 (es) Derivados de benzoimidazol como agentes antiproliferativos
ES2304992T3 (es) Agentes antibacterianos de 3-aminoquinazolin-2,4-diona.
PE20010641A1 (es) Derivados de piperazina como antagonistas del receptor de serotonina 5-ht1b
PE41796A1 (es) Compuesto activo en el receptor de serotonina 5-ht, util en el tratamiento de enfermedades del s.n.c.
TW200716528A (en) Cyclopropanecarboxamide derivatives
PE20010575A1 (es) Derivados de indol y su uso como ligandos del receptor 5ht2
PE20081504A1 (es) Compuestos de biciclocarboxiamida sustituidos
NO20025641D0 (no) Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
PE20020103A1 (es) Derivados de 1-sulfonil-pirrolidina
AR010080A1 (es) Derivados de 1,2,3,4-tetrahidronaftaleno
PE20021043A1 (es) DERIVADOS DE PIRAZINO[1,2-a]INDOL COMO AGONISTAS DEL RECEPTOR 5HT2

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed